Company Search:
Advanced Search
Sponsored Links
Immupharma PLC Company Snapshot
Immupharma PLC operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Immupharma PLC with three other pharmaceutical manufacturers in Europe: N4 Pharma PLC (2017 sales of £109,913.00 [US$144,812.58 ] ), Enorama Pharma AB of Sweden (1.57 million Swedish Kronor [US$177,060.23 ] ), and OptiBiotix Health PLC (£191,073.00 [US$251,742.50 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Immupharma PLC
  Stock Performance Chart for Immupharma PLC
  Stock Data: Recent Stock Performance:
  Current Price (6/22/2018): 24.60p
(Figures in Pounds Sterling)
1 Week 3.8%   13 Weeks -10.9%  
4 Weeks -80.4%   52 Weeks -53.0%  
Immupharma PLC Key Data:
  Ticker: IMM Country: United Kingdom
  Exchanges: LON Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2017 Sales 150,462
(Year Ending Jan 2018).
Employees: 10
  Currency: Pounds Sterling Market Cap: 34,308,988
  Fiscal Yr Ends: December Shares Outstanding: 139,467,430
  Share Type: Ordinary Closely Held Shares: 55,480,170
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.